ULK2 Antikörper (AA 693-938)
Kurzübersicht für ULK2 Antikörper (AA 693-938) (ABIN1886618)
Target
Alle ULK2 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 693-938
-
Aufreinigung
- Purified by antigen-affinity chromatography.
-
Immunogen
- Recombinant protein fragment contain a sequence corresponding to a region within amino acids 693 and 938 of ULK2
-
-
-
-
Applikationshinweise
-
Suggested dilutions:
Western blotting: 1.500-1.3000
Immunohistochemistry: 1.50-1.500
Immunofluorescence: 1.100-1.200 -
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Buffer
- 0.1 M Tris-buffered saline with 10 % Glycerol (pH 7.0).0.01 % Thimerosal was added as a preservative.
-
Konservierungsmittel
- Thimerosal (Merthiolate)
-
Vorsichtsmaßnahmen
- Biohazard Informations: This product contains thimerosal which is hazardous.
-
Lagerung
- 4 °C/-20 °C
-
Informationen zur Lagerung
- Store at -20 °C for long term preservation (recommended). Store at 4 °C for short term use.
-
-
- ULK2 (Unc-51 Like Kinase 2 (ULK2))
-
Andere Bezeichnung
- ULK2
-
Hintergrund
-
This gene encodes a protein that is similar to a serine/threonine kinase in C.elegans which is involved in axonal elongation.The structure of this protein is similar to the C.elegans protein in that both proteins have an N-terminal kinase domain, a central proline/serine rich (PS) domain, and a C-terminal (C) domain.The gene is located within the Smith-Magenis syndrome region on chromosome 17.Alternatively spliced transcript variants encoding the same protein have been identified.[provided by RefSeq]
-
Molekulargewicht
- 113 kDa
-
Gen-ID
- 9706
-
NCBI Accession
- NM_014683, NP_055498
-
Pathways
- Regulation of Cell Size, Autophagie
Target
-